Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018226081) ANTIBODY SPECIFICALLY BINDING TO ACETYLATED HUMAN BUBR1 AND USE THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/226081 International Application No.: PCT/KR2018/006601
Publication Date: 13.12.2018 International Filing Date: 11.06.2018
IPC:
C07K 16/18 (2006.01) ,G01N 33/50 (2006.01) ,G01N 33/574 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
Applicants:
서울대학교 산학협력단 SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION [KR/KR]; 서울시 관악구 관악로 1 1, Gwanak-ro, Gwanak-gu, Seoul 08826, KR
Inventors:
이현숙 LEE, Hyunsook; KR
권미선 KWON, Mi-Sun; KR
박인애 PARK, In Ai; KR
Agent:
유미 특허법인 YOU ME PATENT AND LAW FIRM; 서울시 강남구 테헤란로 115 115 Teheran-ro Gangnam-gu Seoul 06134, KR
Priority Data:
10-2017-007252609.06.2017KR
Title (EN) ANTIBODY SPECIFICALLY BINDING TO ACETYLATED HUMAN BUBR1 AND USE THEREOF
(FR) ANTICORPS SE LIANT SPÉCIFIQUEMENT À LA BUBR1 HUMAINE ACÉTYLÉE ET UTILISATION ASSOCIÉE
(KO) 아세틸화된 인간 BubR1에 특이적으로 결합하는 항체 및 그 용도
Abstract:
(EN) Disclosed are an anti-BubR1 antibody and a use thereof. Specifically, provided are an anti-BubR1 antibody specifically binding to acetylated human BubR1, a hybridoma that produces the antibody, and a use of the antibody.
(FR) La présente invention concerne un anticorps anti-BubR1 et une utilisation associée. Plus particulièrement, l'invention concerne un anticorps anti-BubR1 se liant spécifiquement à la BubR1 humaine acétylée, un hybridome qui produit l'anticorps, et une utilisation de l'anticorps.
(KO) 항 -BubR1 항체 및 이의 용도에 관한 것으로, 구체적으로, 아세틸화된 인간 BubR1에 특이적으로 결합하는 항 -BubR1 항체, 상기 항체를 생산하는 하이브리도마,및 상기 항체의 용도가 제공된다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)